The Molecular Biology Society of Japan

The 41st Annual Meeting of the Molecular Biology Society of Japan

The 41st Annual Meeting of the Molecular Biology Society of Japan

Nov 28, 2018 - Nov 30, 2018
Pacifico Yokohama

[3LBA-115] New therapeutic strategy for acute myeloid leukemia (AML) using lysosomal function.

〇Aki Inase1, Yimamu Maimaitili1, Yu Mizutani1, Hironobu Minami1, Hiroshi Matsuoka1 (1.Div. Oncol./Hematology, Kobe Univ. Grad. Sch. Med.)

Gemtuzumab ozogamicin, mTORC1/2 inhibitor, AML, ADC

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password